Product Program year 2025 Source: CMS Open Payments

MemoFix Super Elastic Nitinol Staple System

Device Extremity, Lower FF Restoration

PDI 10381780247494

Open in the dashboard

General payments

$66,566

356 payments

Research payments

$0

0 payments

Through program year 2025, $66,566 in general payments and $0 in research payments were reported against MemoFix Super Elastic Nitinol Staple System (Extremity, Lower FF Restoration).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $4,022 54
2024 General $20,392 87
2023 General $36,918 98
2022 General $5,220 116
2021 General $13 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Smith+Nephew, Inc. $66,566 356 payments
Top recipients General payments · program year 2025
  1. Kurt Rode Podiatrist · West Hartford, CT $146 4% · 1 payment
  2. Rafael Gonzalez Podiatrist · Bloomfield, CT $146 4% · 1 payment
  3. Marc Lederman Podiatrist, Foot & Ankle Surgery · West Hartford, CT $146 4% · 1 payment
  4. Lynn Leblanc Podiatrist · Bloomfield, CT $146 4% · 1 payment
  5. Gabriel Gambardella Podiatrist, Foot & Ankle Surgery · Bloomfield, CT $146 4% · 1 payment

The top 5 of 52 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $1,840 52% · 22 practitioners
  2. Podiatrist $973 28% · 10 practitioners
  3. Orthopaedic Surgery $281 8% · 6 practitioners
  4. Podiatrist, Foot Surgery Podiatrist $169 5% · 2 practitioners
  5. Vascular Surgery Surgery $145 4% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Connecticut $2,205 55% · 21 recipients
  2. New York $724 18% · 5 recipients
  3. Pennsylvania $222 6% · 4 recipients
  4. New Mexico $151 4% · 3 recipients
  5. Florida $145 4% · 1 recipient

The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

356 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record